In glioma patients, elevated TMEM115 expression was strongly correlated with adverse prognosis (HR = 1.9, P < 0.05; HR = 1.6, P < 0.05) (Figures 1B, C). This evidence concerns the gene TMEM115 and central nervous system cancer.